ERBB2 and breast cancer: Meanwhile, results show that the presence of MMP9 rs3918242 C allele was significantly associated with decreased chances of HER2 receptor-positive BC (OR = 0.256, 95% CI 0.157–0.419, p = 0.000) (Table 4).